Loading…
Employees: 483
Size SS Innovations International (SSII) is a United States Health Care company (Medical Specialties) with a market value of $423M, the 2812th largest of 3,117 United States companies the cockpit tracks. Shares closed at $2.11 on 6 Nov 2026.
Performance Over six months the shares fell 45.5%, against -16.0% for the median peer and -1.1% for the United States market (cap-weighted) — 3rd lowest of 20 in its peer set.
Growth Revenue grew 90.0% over the last twelve months (peer median +8.4%); the operating margin is -16.2% (peer median 5.2%).
Valuation It trades at 8.0× enterprise value to sales against a peer median of 4.5× (4th most expensive of 21).
Capital Return on invested capital runs 20.0 points below its cost of capital (6.3% WACC).
Next results Next results expected around 16 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $52.3M | $42.4M | $20.6M | $5.88M | $1.44M |
| Revenue growth | — | +106% | +250% | +309% | — |
| Gross profit | $23.6M | $18.4M | $7.94M | $572,790 | -$36,000 |
| EBITDA | -$7.22M | -$7.08M | -$18.6M | -$20.1M | -$2.86M |
| Net income | -$12.4M | -$12.1M | -$19.2M | -$20.9M | -$3.21M |
| Free cash flow | -$18.2M | -$22.2M | -$10.2M | -$15.8M | -$1.44M |
| Capital expenditure | $2.68M | $3.66M | $661,479 | $453,327 | $0 |
| Total debt | $17.9M | $14.4M | $18.2M | $9.28M | $8.27M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | SSII | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -19.8% | -8.6% | 3rd lowest of 21 |
| 6-month return | -45.5% | -16.0% | 3rd lowest of 20 |
| Distance from 52-week high | -72.8% | -37.7% | 3rd lowest of 21 |
| Revenue growth (TTM) | +90.0% | +8.4% | 2nd highest of 21 |
| Operating margin | -16.2% | 5.2% | 6th lowest of 21 |
| EV / Sales | 8.0× | 4.5× | 4th most expensive of 21 |
| ROIC minus cost of capital | -20.0 pp | -2.8 pp | 6th lowest of 19 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| SS Innovations International SSII | United States | $423M | -45% | +90% | -16% | 8.0× | n/a | n/a |
| YD Bio YDES | United States | $423M | -58% | +17% | -883% | 704.2× | n/a | n/a |
| Shoulder Innovations SI | United States | $428M | +56% | +61% | -59% | 5.7× | n/a | n/a |
| Shanghai General Healthy Information & Technology 605186.SS | China | $417M | +3% | +12% | 6% | 8.1× | 55.5% | +3.8% |
| NeuroPace NPCE | United States | $429M | -32% | +12% | -15% | 4.5× | n/a | n/a |
| Shanghai Titan Scientific 688133.SS | China | $432M | -22% | -5% | -5% | 1.5× | n/a | n/a |
| Medcaptain Medical Technology 2041.HK | Hong Kong | $412M | n/a | +19% | 3% | 1.6× | 23.3% | +18.1% |
| 908 Devices MASS | United States | $436M | +29% | +1% | -35% | 5.5× | n/a | n/a |
| SEERS 458870.KS | South Korea | $409M | -70% | +425% | 43% | 5.5× | -9.1% | +247.0% |
| Beijing Succeeder Technology 688338.SS | China | $408M | -15% | -4% | 31% | 5.4× | 9.8% | +3.4% |
| Cerus CERS | United States | $408M | -23% | +14% | -12% | 1.9× | n/a | n/a |
| Shanghai Kehua Bio-Engineering 002022.SZ | China | $407M | -14% | +3% | -45% | 1.9× | n/a | n/a |
| Ningbo Tianyi Medical Appliance 301097.SZ | China | $407M | -20% | +46% | 8% | 4.3× | n/a | n/a |
| Guangdong Transtek Medical Electronics 300562.SZ | China | $406M | -13% | +7% | 11% | 2.0× | -2.5% | -6.0% |
| Guanhao Biotech 300238.SZ | China | $440M | -25% | -7% | 5% | 7.8× | n/a | n/a |
| Chison Medical Technologies 688358.SS | China | $443M | -16% | -1% | 19% | 4.4× | 11.8% | +5.6% |
| Brainsway Ltd Sponsored ADR BWAY | United States | $450M | -35% | +32% | 12% | 6.5× | 34.3% | +18.8% |
| PROTEINA 468530.KS | South Korea | $450M | -2% | -59% | -1,178% | 410.3× | n/a | n/a |
| Hunan Sundy Science and Technology 300515.SZ | China | $453M | -13% | +10% | 27% | 3.7× | 0.9% | +15.6% |
| Taidoc Technology 4736.TW | Taiwan | $395M | 0% | -6% | 18% | 1.9× | -8.0% | -6.6% |
| Eiken Chemical 4549.T | Japan | $454M | -29% | +4% | 6% | 1.5× | n/a | n/a |